These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30049330)

  • 1. Sustained Cardiac Recovery Hinges on Timing and Natural History of Underlying Condition.
    Jaiswal A; Le Jemtel TH; Samson R; Mancini D
    Am J Med Sci; 2018 Jul; 356(1):47-55. PubMed ID: 30049330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.
    Castillero E; Ali ZA; Akashi H; Giangreco N; Wang C; Stöhr EJ; Ji R; Zhang X; Kheysin N; Park JS; Hegde S; Patel S; Stein S; Cuenca C; Leung D; Homma S; Tatonetti NP; Topkara VK; Takeda K; Colombo PC; Naka Y; Sweeney HL; Schulze PC; George I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1463-H1476. PubMed ID: 30141986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study.
    Bonios MJ; Koliopoulou A; Wever-Pinzon O; Taleb I; Stehlik J; Xu W; Wever-Pinzon J; Catino A; Kfoury AG; Horne BD; Nativi-Nicolau J; Adamopoulos SN; Fang JC; Selzman CH; Bax JJ; Drakos SG
    Circ Cardiovasc Imaging; 2018 Apr; 11(4):e007117. PubMed ID: 29653930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
    Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
    Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
    Patel SR; Saeed O; Murthy S; Bhatia V; Shin JJ; Wang D; Negassa A; Pullman J; Goldstein DJ; Maybaum S
    J Heart Lung Transplant; 2013 Mar; 32(3):305-12. PubMed ID: 23415314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy.
    Altemose GT; Gritsus V; Jeevanandam V; Goldman B; Margulies KB
    J Heart Lung Transplant; 1997 Jul; 16(7):765-73. PubMed ID: 9257259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular changes occurring during reverse remodelling following left ventricular assist device support.
    Birks EJ; George RS
    J Cardiovasc Transl Res; 2010 Dec; 3(6):635-42. PubMed ID: 20820974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.
    Miyagawa S; Toda K; Nakamura T; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Saito T; Sawa Y
    Surg Today; 2016 Feb; 46(2):149-54. PubMed ID: 25840890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial size and fibrosis changes during left ventricular assist device support.
    Yamada Y; Saito S; Nishinaka T; Yamazaki K
    ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Molecular Comparison of Pediatric and Adult Reverse Remodeling With Ventricular Assist Devices.
    Weia BC; Adachi I; Jacot JG
    Artif Organs; 2015 Aug; 39(8):691-700. PubMed ID: 25865791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial microRNAs associated with reverse remodeling in human heart failure.
    Sucharov CC; Kao DP; Port JD; Karimpour-Fard A; Quaife RA; Minobe W; Nunley K; Lowes BD; Gilbert EM; Bristow MR
    JCI Insight; 2017 Jan; 2(2):e89169. PubMed ID: 28138556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.
    Qiu Q; Chen YX; Mai JT; Yuan WL; Wei YL; Liu YM; Yang L; Wang JF
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):329-37. PubMed ID: 25392055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.